Utilizing feline oral squamous cell carcinoma patients to develop NQO1-targeted therapy

Developing effective therapies for the treatment of advanced head-and-neck squamous cell carcinoma (HNSCC) remains a major challenge, and there is a limited landscape of effective targeted therapies on the horizon. NAD(P)H:quinone oxidoreductase 1 (NQO1) is a 2-electron reductase that is overexpress...

Descripción completa

Detalles Bibliográficos
Autores principales: Lundberg, Alycen P., Boudreau, Matthew W., Selting, Kim A., Chatkewitz, Lindsay E., Samuelson, Jonathan, Francis, Joshua M., Parkinson, Elizabeth I., Barger, Anne M., Hergenrother, Paul J., Fan, Timothy M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274297/
https://www.ncbi.nlm.nih.gov/pubmed/34246985
http://dx.doi.org/10.1016/j.neo.2021.06.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274297/
https://www.ncbi.nlm.nih.gov/pubmed/34246985
http://dx.doi.org/10.1016/j.neo.2021.06.008

Ejemplares similares